Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × selinexor × Clear all

NCT02025985 2023-01-26

SIGN

Phase 2 Completed

116 enrolled 21 charts

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms